Related Experiment Video
Updated: Sep 20, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
[Guideline for hyperlipidemia]
1Department of Clinical Laboratory Medicine, Gifu University School of Medicine, Gifu 500-8705.
Insights
The Japan Atherosclerosis Society (JAS) guidelines for hyperlipidemia diagnosis and treatment were updated in 2002, maintaining previous diagnostic values for cholesterol and triglycerides. Lifestyle changes are recommended before drug therapy for abnormal results.
Area of Science:
- Cardiovascular Medicine
- Public Health
Background:
- The Japan Atherosclerosis Society (JAS) has developed guidelines for managing atherosclerotic cardiovascular diseases since 1987.
- Previous guidelines were published in 1997, with significant updates in 2002.
Purpose of the Study:
- To present the updated JAS guidelines for the diagnosis and treatment of atherosclerotic cardiovascular diseases.
- To define diagnostic criteria and management goals for hyperlipidemia and coronary heart disease.
Main Methods:
- The 2002 guidelines incorporated findings from the J-LIT study and other relevant research.
- Diagnostic values for total cholesterol (TC), LDL-C, HDL-C, and triglycerides (TG) were established.
- Management goals were set for coronary heart disease patients based on risk factor stratification.
Main Results:
- Diagnostic criteria for hyperlipidemia: TC ≥ 220 mg/dL, LDL-C ≥ 140 mg/dL, HDL-C < 40 mg/dL, TG ≥ 150 mg/dL.
- Recommended TC level for males < 45 with no risk factors is < 240 mg/dL.
- Treatment initiation prioritizes lifestyle and dietary modifications over drug therapy for abnormal results.
Conclusions:
- The updated JAS guidelines provide a framework for diagnosing and managing atherosclerotic cardiovascular diseases.
- Physician's clinical judgment remains paramount in determining individual patient treatment plans.
- Emphasis is placed on a stepwise approach to treatment, starting with lifestyle interventions.
Abstract:
The guideline for hyperlipidemia was first discussed at the meeting of the Japan Atherosclerosis Society in 1987 and further discussed and published for the first time by the Society in 1997. Thereafter, a new guideline "Japan Atherosclerosis Society(JAS) Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Diseases" was released in September 2002 taking the results of J-LIT study and others into consideration. The diagnostic values of TC, LDL-C, HDL-C and TG for hyperlipidemia are > or = 220 mg/dl, > or = 140 mg/dl, < 40 mg/dl, and > or = 150 mg/dl, respectively, the same figures as those of a previous guideline in 1997. Other criteria were made as management goals for patients with coronary heart disease in each category, classified by the number of risk factors. According to the criteria, the recommended level of TC is < 240 mg/dl in males aged less than 45 with no risk factors. If any result is abnormal, treatment by life style and dietary modification should be started first and drug therapy should be a second choice. It should be noted that this guideline helps to inform, not replace, the physician's clinical judgement, which must ultimately determine the appropriate treatment for each individual.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Cholesterol: Significance and Regulation
Considering cholesterol and...